Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have fully understood and voluntarily signed the consent form for the study
- People who are over 18 years old at the time of signing the consent form (any gender)
- People whose kidneys are functioning at a certain level before surgery, measured by a blood test called eGFR, with a result above 45 ml/min/1.73m² using a specific calculation method
- People for whom a doctor has discussed and decided on a treatment plan involving either full or partial surgical removal of a kidney
- People with an ECOG performance score of 0 to 2, meaning they are able to carry out daily activities to at least a moderate degree (confirm with trial site)
- People who are willing and able to attend all required visits, treatments, tests, and follow all study procedures
Who may not be able to join:
- People who have only one kidney, or whose other kidney is functioning very poorly (eGFR below 15 ml/min/1.73m²)
- People who are already dependent on kidney replacement treatments such as dialysis before surgery
- People whose surgery could not be completed as originally planned
- People whose cancer has spread to lymph nodes, distant parts of the body, or into nearby blood vessels
- People whose healthy kidney has previously been treated with radiation therapy, ablation, or other surgery
- People with a known allergy to ultrasound contrast agents (a substance used in certain imaging scans)
- People with medical conditions that make contrast-enhanced ultrasound unsafe, such as certain heart or lung conditions (confirm with trial site)
- People with unstable blood pressure or circulation problems, including persistently low blood pressure, uncontrolled heart failure, active bleeding anywhere in the body, or very low blood or platelet counts
- People with structural or functional problems affecting the urinary system that cannot be corrected quickly, such as certain kidney shape variations, narrowed kidney arteries, urinary blockages, or a history of previous kidney surgery
- People who require a long-term urinary catheter
- People who have another illness that is expected to limit their life expectancy to less than six months
- People who have taken part in, or are currently taking part in, another clinical study within the 30 days before joining this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 15720625951
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
new baseline estimates glomerular filtration rate(NB-eGFR); Rec-Ischemia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.